Livingston, R. B., Barlow, W. E., Kash, J. J., Albain, K. S., Gralow, J. R., Lew, D. L., . . . Hortobagyi, G. N. (2011). SWOG S0215: A Phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer.

Livingston, Robert B., William E. Barlow, Joseph J. Kash, Kathy S. Albain, Julie R. Gralow, Danika L. Lew, Lawrence E. Flaherty, Melanie E. Royce, e Gabriel N. Hortobagyi. SWOG S0215: A Phase II Study of Docetaxel and Vinorelbine Plus Filgrastim With Weekly Trastuzumab for HER2-positive, Stage IV Breast Cancer. 2011.

Livingston, Robert B., et al. SWOG S0215: A Phase II Study of Docetaxel and Vinorelbine Plus Filgrastim With Weekly Trastuzumab for HER2-positive, Stage IV Breast Cancer. 2011.